Gracell Biotechnologies Inc. (GRCL) — Tangible Net Worth Ratio
Gracell Biotechnologies Inc. (GRCL) has a Tangible Net Worth Ratio of 100.0% as of September 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.62 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See GRCL working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Gracell Biotechnologies Inc. Tangible Net Worth Ratio (2018–2022)
This chart shows how Gracell Biotechnologies Inc.'s Tangible Net Worth Ratio has changed across 5 annual periods from 2018 to 2022. As of September 2023, the ratio stands at 100.0%, reflecting net assets of $1.62 Billion with intangible assets of $0.00 USD. Also explore GRCL net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Gracell Biotechnologies Inc. (2018–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Gracell Biotechnologies Inc. from 2018 to 2022, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see GRCL market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $1.38 Billion | $0.00 | $1.66 Billion | ▲ +0.0 pp |
| 2021 | 100.0% | $1.83 Billion | $0.00 | $2.06 Billion | ▲ +0.0 pp |
| 2020 | 100.0% | $819.66 Million | $0.00 | $964.95 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $255.36 Million | $0.00 | $412.22 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $2.38 Million | $0.00 | $148.52 Million | — |